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Abstract 
 
Objective 
To examine explanations for the higher rates of male mortality in two Scottish cohorts 
compared with a cohort in south-east England for which similar data were collected.  
Design 
Comparison of three cohort studies which recruited participants in the late 1960s and early 
1970s.  
Setting 
Central Scotland and south-east England.  
Participants 
A total of 13,884 men aged 45-64 years at recruitment in the Whitehall occupational cohort 
(south-east England), 3,956 men in the Collaborative occupational cohort and 6,813 men in 
the Renfrew & Paisley population-based study (both central Scotland).  
Main outcome measures 
All-cause and cause-specific mortality.  
Results 
All-cause mortality was 25% (age-adjusted hazard ratio 1.25, 95% confidence interval 
(CI)1.21 to 1.30) and 41% (hazard ratio 1.41 (95% CI 1.36 to 1.45) higher in the Collaborative 
and Renfrew & Paisley cohorts respectively compared to the Whitehall cohort. The higher 
mortality rates were substantially attenuated by social class (to 8% and 17% higher 
respectively), and were effectively eliminated upon the further addition of the other 
baseline risk factors, such as smoking habit, lung function and pre-existing self-reported 
morbidity. Despite this, coronary heart disease mortality remained 11% and 16% higher, 
stroke mortality 45% and 37% higher, mortality from accidents and suicide 51% and 70% 
higher, and alcohol-related mortality 46% and 73% higher in the Collaborative and Renfrew 
& Paisley cohorts respectively compared with the Whitehall cohort in the fully adjusted 
model.  
Conclusions 
The higher all-cause, respiratory, and lung cancer male mortality in the Scottish cohorts was 
almost entirely explained by social class differences and higher prevalence of known risk 
factors, but reasons for the excess mortality from stroke, alcohol-related causes, accidents 
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and suicide remained unknown.  
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Introduction 
Life expectancy in Scotland was comparable to the rest of western Europe until around 
1950.1 From 1950 onwards, all-cause mortality rates in Scotland have improved more slowly 
than elsewhere in western Europe and diverged from those in England & Wales.2 3 Between 
1950 and 1980, the higher mortality in Scotland was primarily driven by deaths due to 
cardiovascular disease, stroke, respiratory disease and cancer amongst men and women of 
middle age. It is believed that much of this higher mortality rate may be accounted for by  
greater poverty and the consequences of this,4 but there are no analyses of mortality and 
deprivation comparing Scotland and England prior to the creation of postcodes (zip-codes) 
in the 1970s.  
 
From the 1980s onwards the pattern of mortality changed in Scotland. Mortality rates 
related to alcohol, illicit drugs, suicide and violence increased in young men and young 
women.2 3 In Scotland overall, and in west central Scotland in particular, this meant a rise in 
male mortality for young adult males in absolute terms.5 6 Although the mortality rates for 
cardiovascular disease, stroke and cancer in middle age improved from this time, they 
remained high relative to England & Wales and the rest of western Europe. In 1981, all-
cause mortality in Scotland was 12% higher than in England & Wales, rising to 15% higher by 
2001. However, the proportion of this rising excess explained by the Carstairs deprivation 
index (a measure of area deprivation derived from Census data on social class, 
overcrowding, car ownership and unemployment)7 actually declined from 62% in 1981 to 
47% in 2001.  
 
The increasing proportion of the mortality gap between Scotland and England unexplained 
by deprivation has been termed the ‘Scottish Effect’.8 The phenomenon of higher mortality 
not entirely explained by deprivation has also been confirmed at city level, where 
premature mortality in Glasgow is seen to be 30% higher than in the equally deprived 
English cities of Liverpool and Manchester (as approximated by income-deprivation 
prevalence in small areas),9 and in mortality from ischaemic heart disease in Scotland 
compared to England using individual data.10 The suggestion that something additional to 
deprivation is impacting on health in Scotland is also supported by the rising premature 
mortality in Scotland’s persistently deprived areas in contrast to the declining trends seen in 
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England. 11 
 
The changing mortality pattern in Scotland emerged approximately one decade after the 
recruitment of participants into three cohorts in south-east England (the Whitehall I study of 
male London based civil servants between 1967 and 197012) and central Scotland (the 
Collaborative Study of employees from a wide variety of workplaces around Glasgow, 
Clydebank and Grangemouth screened between 1970 and 197313; and the general 
population Renfrew & Paisley study carried out between 1972 and 197614). The selected 
participants in the two occupational cohorts were subject to the ‘healthy worker effect’ 
since they included only those who were in employment. The methods used and the data 
collected in the Whitehall cohort were very similar to that in the Scottish cohort studies.  
 
The three cohort studies therefore provide the opportunity to look at the higher mortality in 
Scotland compared to England through a different lens, by examining the extent to which 
any mortality differences between the cohorts can be explained by social class and 
biological characteristics and behavioural risk factors.  
 
Methods 
The studies 
In the Whitehall study, 18,403 men aged 40-64 years were examined between 1967 and 
1969.12 Of this total, 15,395 of the men were aged 45-64 years (the age group recruited in 
the Renfrew & Paisley cohort). The Collaborative cohort of men and women was recruited 
from 27 workplaces in Glasgow, Grangemouth, and Clydebank (in central Scotland) between 
1970 and 1973.13 Response rates were available for the workplaces from which 87% of the 
sample was recruited. For these sites 70% of those invited completed the questionnaire and 
attended for examination. The achieved sample included 6,022 men, of whom 4,021 were 
aged 45-64 years. The Renfrew & Paisley general population study was carried out between 
1972 and 1976. The sampling frame was residents of the towns of Renfrew & Paisley (in 
central Scotland) aged 45-64 years, and a 78% response was achieved. Full details of the 
study methodology have been reported previously.14 A total of 7,049 men were included in 
the study. Due to their geographical locations, there were 26 men who took part in both the 
Collaborative and Renfrew & Paisley studies. To ensure they were only included once in the 
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combined analysis, their records from the Renfrew & Paisley study were not used, leaving 
7,023 men. 
 
The questionnaire and examination procedures were similar in all three studies as they had 
been developed from an earlier occupational health survey carried out in the west of 
Scotland between 1964 and 1967 and there was close collaboration between the cohort 
founders Victor Hawthorne and Geoffrey Rose.15 Cohort participants completed a 
questionnaire to collect data on demographics, occupation and smoking habit. In the 
Scottish cohorts, occupation was coded and assigned to social class using the Registrar 
General Classification. In the Whitehall study, civil service employment grade was 
categorised as administrative, professional or executive, clerical, and "other grades" (men in 
‘messenger’ and other unskilled manual jobs) and matched to the Registrar General 
Classification of social class.16 Smoking was categorised according to cigarette, pipe or cigar 
use (as "never smoker", "ex-cigarette smoker", "current cigarette smoker" or “current pipe 
or cigar smoker”). In addition, the number of cigarettes smoked per day was recorded and 
controlled for in the smoking adjusted analyses. The Rose angina questionnaire17 and the 
Medical Research Council respiratory questionnaire18 were also included. As part of these 
questionnaires persistent phlegm was defined as: usually bringing up phlegm from the chest 
first thing in the morning on most days for three months during winter each year. “Infective 
phlegm” was defined as: usually bringing up phlegm from the chest first thing in the 
morning in winter and having had a period of increased cough and phlegm lasting for three 
weeks or more in the previous three years. Breathlessness was defined as a positive 
response to the question: “Do you get short of breath walking with people of your own age 
on level ground?” and bronchitis as having persistent or “infective” phlegm and being 
breathless. Angina was considered present if chest pain or discomfort when walking uphill 
or hurrying was cited in the sternum or the left chest and arm; caused the subject to stop or 
slow down; went away when the subject stopped or slowed down; and went away in 10 
minutes or less. 
 
The examination measurements included height, weight, blood pressure, lung function, a six 
lead electrocardiogram and plasma cholesterol concentration in all three cohorts. Heights 
were measured with shoes on in the Whitehall study, so a deduction of 2.54cm (1 inch) in 
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height was made for each participant to improve comparability with the other cohorts (a 
sensitivity analyses was also conducted using a deduction of 1.27cm, or ½ inch). In the 
Whitehall study, the cholesterol measures taken later in the baseline data collection period 
were systematically lower than those at earlier times and may have been adversely affected 
by a change in the concentration of the laboratory standard over time. The cholesterol 
values were therefore adjusted to their predicted values as if they were taken at the start of 
the baseline data collection period (which had the effect of increasing the mean cholesterol 
in the Whitehall cohort from 5.12 to 5.69).  
 
The electrocardiogram was coded according to the Minnesota system19 and was regarded as 
positive for ischaemia if Q/QS items (codes 1.1-3), ST/T items (codes 4.1-4 or 5.1-3), or left 
bundle branch block (code 7.1) were present. Forced expiratory volume in 1 second (FEV1) 
was also recorded. The FEV ratio was calculated for each individual as the ratio of measured 
FEV1 divided by predicted FEV calculated from the subjects’ age and height based on an 
equation derived in those men free of respiratory symptoms in the Renfrew & Paisley study. 
 
Records were traced and flagged at the National Health Service Central Registry. Death 
certificates coded according to the eighth, ninth or tenth revision of the International 
Classification of Diseases (ICD), were obtained. Mortality was classified as being due to 
coronary heart disease (ICD8/9: 410-414; ICD10: I20-I25), stroke (ICD8/9: 430-438; ICD10: 
I60-I69), respiratory disease (ICD8/9: 460–519; ICD10: J00-J99), lung cancer (ICD8/9: 162; 
ICD10: C33-C34), accidents and suicide (ICD8/9: E800-E999; ICD10: S00-Y98) or alcohol-
related deaths (ICD8/9: 141, 143-6, 148-9, 150, 155, 161, 291, 303, 571 or E800-E999; 
ICD10: C01-C06,  C10, C13-C15, C22, C32, F10, K70, K74.6 or S00-Y98). Mortality follow-up 
was until 31st December 2008.  
 
Statistical analysis 
We excluded from the three studies a total of 1,775 (6.8%) men with missing values for any 
of the covariates and those who were not followed up for mortality. This resulted in an 
analytic sample of 24,653 men (13,884 Whitehall, 3,956 Collaborative and 6,813 Renfrew & 
Paisley). The prevalence of baseline characteristics in the three studies was adjusted for age 
(5-year age groups) using direct standardisation with the combined population as the 
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standard. Differences in prevalence between the studies were tested for significance using 
the Mantel-Haenzsel test. For continuous variables, least-squares means were used to 
present the age-adjusted means and the significance of the study group variable was used 
to test for heterogeneity.    
 
Mortality rates, by follow-up period and overall, were calculated using person years at risk 
and were standardised for age at entry as above. Hazard ratios and 95% confidence intervals 
for mortality in the Scottish cohorts compared to the Whitehall study were computed using 
Cox’s proportional hazards regression model with follow up time as the time scale. Initially, 
models were adjusted for age and each of the potential explanatory factors separately. 
Subsequently, multiply adjusted models controlled for all factors both including and 
excluding social class. An analysis stratified by social class was also performed adjusting for 
all other factors. Adjustment for BMI in these models was achieved by including both linear 
and quadratic BMI terms.20 All other continuous measures were controlled for by including 
a single linear term. To adjust for smoking we used three indicator variables to compare ex-
smokers, pipe/cigar smokers and current smokers with never smokers (with one indicator 
variable for each comparison) and fitted a term that adjusted for the numbers of cigarettes 
smoked per day in the current smokers. Proportional hazard models were also fitted within 
each of the social class groups to examine the magnitude of the hazard ratios and to assess 
the effect of controlling for the explanatory factors within each group. Further models were 
fitted to compare the hazard ratios and the effect of the adjustments by stratifying the 
follow-up into periods 0-9 years, 10-19 years and ≥20 years.  
 
Results 
The distribution of baseline characteristics of the men in the three cohort studies are 
presented in table 1. As expected, the Whitehall cohort has a much higher proportion of 
individuals in social classes I and II (72.7%) compared to the Collaborative study (30.4%) and 
Renfrew & Paisley study (19.3%). The high proportion of people in social class IIIM, IV and V 
in the Collaborative (52.8%) and Renfrew & Paisley (69%) cohorts is unusual for a study of 
this type, but reflects the social class make-up of the communities from which the cohorts 
are drawn. Cholesterol levels were similar in the Collaborative and Renfrew & Paisley 
studies, and much lower in the Whitehall study. Blood pressure was similar in the Whitehall 
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and Collaborative studies, and higher in the Renfrew & Paisley study. BMI was highest in the 
Renfrew & Paisley study and lowest in the Collaborative study. Men in the Whitehall study 
were the tallest and had the best FEV1 and men in the Renfrew & Paisley study the shortest 
with the worst FEV1. The largest baseline differences in the questionnaire measures relate 
to smoking (where there is a higher proportion of ex-smokers in the Whitehall study and 
lower proportion of current smokers) and self-reported morbidity (for cardiorespiratory 
symptoms and previous diagnoses).   
 
Table 2 gives the number of deaths and the age standardised mortality rates in each cohort 
by cause of death. The largest number of deaths was due to coronary heart disease (CHD), 
followed by respiratory causes, stroke and lung cancer. The mortality rates increase across 
the follow-up periods since the men are older in the later periods of follow-up and are 
consistently higher in the Renfrew & Paisley than the Collaborative cohort and the Whitehall 
cohort (at 41.6, 38.7 and 35.8 deaths per 1,000 person years respectively). The relative risk 
of mortality after age-adjustment was higher in both Scottish cohorts than in the Whitehall 
study for each specific cause and for all causes (Table 3). All-cause mortality was 25% and 
41% higher, CHD mortality 32% and 41% higher, stroke mortality 55% and 73% higher, 
respiratory mortality 5% and 17% higher, lung cancer mortality 65% and 98% higher, 
mortality from accidents and suicide was 77% and 100% higher, and alcohol-related 
mortality 73% and 128% higher in the Collaborative and Renfrew & Paisley cohorts 
respectively as compared to the Whitehall cohort. The higher mortality rates were 
substantially attenuated with the addition of socio-economic position to the model, but 
remained higher for all-causes (8% and 17%), CHD (17% and 22%), stroke (45% and 60%), 
lung cancer (16% and 30%), accidents and suicide (56% and 70%), and alcohol-related 
causes (47% and 85%). The addition of single biological or behavioural factors in addition to 
age in the model (including smoking, FEV1, cardio-respiratory symptoms or history, height, 
blood pressure and cholesterol) were unable to explain as much of the higher all-cause (or 
any of the specific causes) mortality in the Scottish cohorts as socio-economic position (with 
the exceptions of FEV1 for CHD mortality and blood pressure for stroke mortality, in the 
Renfrew & Paisley study).  
 
After adjusting for all risk factors except social class, all-cause mortality remained 9% and 
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7% higher, CHD mortality remained 16% and 1% higher, stroke mortality 44% and 36% 
higher, lung cancer mortality 24% and 38%, mortality due to accidents and suicide 57% and 
78% higher and alcohol-related mortality 56% and 88% higher in the Collaborative and 
Renfrew & Paisley cohorts respectively compared to the Whitehall cohort. Respiratory 
mortality adjusts to be lower in the Scottish cohorts (Table 3), despite it being higher before 
adjustment for the earliest time period after baseline data collection (Table 2).  
 
The fully adjusted model (including social class and all other explanatory factors together) 
explained almost all of the mortality excess in the Scottish cohorts for all-cause mortality 
but there remained some unexplained excess for the specific causes. Stroke mortality 
remained 45% and 37% higher, mortality from accidents and suicide 51% and 70% higher, 
and alcohol-related mortality 46% and 73% higher in the Collaborative and Renfrew & 
Paisley cohorts respectively compared with the Whitehall cohort. CHD mortality remained 
11% higher in the Collabarative study and lung cancer remained 16% higher in the Renfrew 
& Paisley study in the fully adjusted model as compared to the Whitehall study. As before, 
respiratory mortality appeared to be lower in the Scottish cohorts with addition of all of the 
explanatory factors (Table 3).  
 
Given the markedly different social class composition of the three cohorts, the baseline 
characteristics and hazard ratios adjusted for the biological and behavioural risk factors are 
also presented stratified by social class in tables 4 and 5. The differences in baseline risk 
factors were less marked after stratification. Cholesterol levels were lower in the Whitehall 
study compared to the Scottish cohorts within each social class strata. Systolic and diastolic 
blood pressure were lower in each strata in the Whitehall cohort than in the Renfrew & 
Paisley cohort, but was higher in each strata than the Collaborative cohort with the 
exception of systolic blood pressure amongst those in strata IIIM, IV & V. Mean height in 
social classes I & II and IIINM were highest in the Collaborative study and lowest in the 
Renfrew & Paisley study (but highest in the Whitehall study in social classes IIIM, IV & V).  
Cigarette smoking was more prevalent in social class I & II in the Scottish cohorts compared 
to Whitehall, but not in the other social class strata. However, amongst those smokers, 
there were a greater mean number of cigarettes smoked per person in the Scottish cohorts 
for each social class strata. FEV1 was highest, and infective phlegm least common, in the 
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Whitehall study except amongst those in social class IIINM where the mean FEV1 was 
highest and prevalence of infective phlegm lower, in the Collaborative study. The proportion 
with angina was higher in the Scottish cohorts but there was no consistent pattern for 
previous MI or for breathlessness. The prevalence of chronic bronchitis was lowest in the 
Collaborative study in all social classes.  
 
Table 5 shows that there is an excess in all-cause mortality in social class I & II of 9% in the 
Collaborative and 22% in the Renfrew & Paisley study compared to Whitehall after age 
adjustment, but the excesses estimated in the other social class strata are not so large or 
precise (3% and 11% for social class IIINM, and 6% and 13% in social classes IIIM, IV and V, 
for the Collaborative and Renfrew & Paisley cohorts respectively) and those for the 
Collaborative study may be due to chance. Adding the other baseline characteristics to the 
model completely removes the excess mortality in the Scottish cohorts within each social 
class strata.  
 
Table 6 shows the differences in mortality between the cohorts stratified by the follow-up 
time. It shows that the hazard ratios in the Scottish cohorts in comparison with Whitehall 
declined over time. The excesses in the 10-19yr period are slightly less well explained 
whereas the smaller excesses in the ≥20yr period are completed explained (from 1.10 and 
1.01 in the first 10 years of follow-up to 0.96 and 0.95 after >20 years of follow-up in the 
fully adjusted model in the Collaborative and Renfrew & Paisley cohorts respectively).  
 
The sensitivity analyses using a smaller height correction for measurement in shoes in the 
Whitehall cohort (of 1.27cm as opposed to 2.54cm) are shown in Web-tables 7 and 8. The 
impact on the hazard ratios is small and does not change the overall findings.  
 
Discussion 
The aim of the study was to examine explanations for the higher rates of male mortality in 
Scotland compared to England using the data from three cohort studies. Compared with the 
Whitehall cohort in south-east England, male mortality rates were 25% higher in the 
Scottish occupational Collaborative cohort and 41% higher in the Scottish population-based 
Renfrew & Paisley cohort. Adjustment for socio-economic position explained most of this 
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higher mortality because of the stark differences in social class distribution between the 
cohorts. These observations were confirmed when we stratified the samples according to 
SES and period of follow-up. Although all-cause mortality was largely explained, there 
remained substantial excess mortality from stroke, alcohol-related causes, accidents and 
suicide which were unexplained by the baseline risk factors. Thus, in these cohorts of 
middle-aged men recruited during the late 1960s and early 1970s, most of the higher total 
mortality in the Scottish cohorts can be explained by social class, and almost entirely by 
combining social class with the higher prevalences of some known risk factors such as the 
number of cigarettes smoked, FEV1 and pre-existing self-reported morbidity. This resonates 
with the conclusion of an earlier comparison of these cohorts using a much shorter follow-
up time.21  
 
Strengths and weaknesses of the study 
This study provides a unique insight into the higher mortality in Scotland and the ‘Scottish 
Effect’ by using very similar cohort study data from Scotland and England to adjust for 
baseline differences in characteristics known to influence health outcomes. It therefore 
provides a complementary analysis to the existing ecological analyses8 9 and studies using 
individual mortality data with a shorter follow-up period.10 It uses individual-level data and 
includes several objective biological measures in addition to self-reported behaviours and 
morbidity.  
 
Two of the cohorts were drawn from workplaces and so may the results not be applicable to 
the general population. There are very large baseline differences between the Whitehall 
cohort and the Scottish cohorts relating to the much higher proportion of individuals in 
social class I and II in Whitehall. Although this is adjusted for in the model, it is possible that 
there remains confounding due to the very different types of occupations recruited in the 
studies (such as the higher proportion of manual workers, and the potential for direct 
occupational exposures,22 in the Collaborative study). We have therefore presented 
analyses stratified by broad social class categories to reduce the potential for residual 
confounding. However, there may be other unmeasured aspects of social class and 
deprivation which are not captured in this measure (for example, area-based deprivation23), 
and the process of combining social class categories in order to provide sufficient precision 
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of hazard ratio estimates, may have under-differentiated the social differences and left 
residual confounding.  
 
The slightly later period of recruitment in the Scottish cohorts, against a background of 
population health improvements as was seen in the UK at this time, may have resulted in an 
underestimate of the mortality difference between the cohorts since a cohort recruited 
slightly earlier would have been expected to have had higher mortality.  
 
The sensitivity analysis of the height correction in the Whitehall cohort, to allow for 
measurement with shoes on, did not make a large difference to the adjusted hazard ratios 
and so is unlikely to endanger the validity of the analysis. The sensitivity analyses which 
stratified by period of follow-up showed similar patterns of results within each period 
suggesting that the decline in the hazard ratios between the Scottish and Whitehall cohorts 
over time is unlikely to have affected the overall results.  The limited sample sizes in the 
analyses stratified by social class make the estimates of the excess imprecise and make it 
difficult to be certain that the observed higher mortality rates in the Scottish cohorts are not 
due to chance.  
 
Plasma cholesterol levels are a potentially important explanatory factor in the cohort 
comparisons because they are, on average, lower in the Whitehall cohort. Unfortunately, 
the cholesterol measures in the Whitehall study demonstrated a downward trend over time 
between the first samples taken and later samples, suggesting that there may be a 
systematic error (towards an underestimate) in the measures related to a change in the 
laboratory standard. We have therefore applied a correction factor based on the predicted 
cholesterol level at the start of the analysis period, but this may not have fully eliminated 
the bias in favour of lower cholesterol in the Whitehall cohort. This issue was discussed in 
earlier publications of data from this cohort,24 and the possibility of some small residual bias 
is reinforced by the finding in the British Regional Heart Health study of no difference in 
plasma cholesterol levels between the Scottish sample towns and English sample towns.25 
Overall, given the small impact of cholesterol on the hazard ratios, it is unlikely that any 
remaining bias would have a large impact on the overall results.  
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We were limited by a lack of comparative data on alcohol intake, physical activity and diet in 
the cohorts. It may not therefore be surprising that alcohol-related deaths and mortality 
due to accidents and suicide were not explicable across the cohort studies given that the 
baseline risk factors captured in these cohorts were designed to explore cardiovascular 
disease aetiology. However, given that the fully adjusted model accounts for all of the 
excess all-cause mortality in the Scottish cohorts, this does not seem to have been 
important for all-cause mortality.  
 
There were no further consistent waves of data collection across all three cohorts to allow 
changes in occupation, socioeconomic circumstances or risk factors over time to be 
accounted for. Given that changes are likely to be socially patterned (for example, smoking 
cessation and medical treatment for hypertension are both likely to have been more 
common amongst social classes I & II, and there was a marked rise in alcohol-related 
mortality in deprived areas during the 1990s26 and a large increase in relative poverty in 
Scotland during the 1980s and 1990s27), this could have underestimated the impact of these 
risk factors.  
 
A generalisation of the findings of this study to the populations of Scotland and England & 
Wales has to be cautious since the Whitehall and Collaborative studies are occupational 
cohorts and unlikely to be representative of the population as a whole (because of the 
‘healthy-worker’ effect). Furthermore, we did not have comparable data for women to carry 
out any analyses for females.  
 
Comparison with previous studies 
A recent synthesis of the various hypotheses to explain the higher mortality in Scotland 
noted that there are two distinct time phases in the pattern.28 29 The earlier phase from 
around 1950 to 1980 saw higher mortality rates in Scotland as compared to the rest of 
western Europe largely due to deaths from cardiovascular disease, stroke, respiratory 
disease and cancer in middle-aged men and women. Prior to this, Scotland had a similar life 
expectancy to most other western European countries1 but with marked inequalities in 
mortality within the nation. From 1980 onwards the pattern of mortality changed. Causes of 
death which had thus far been relatively uncommon in Scotland such as liver cirrhosis, illicit 
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drug-related deaths, suicide and violent deaths began to increase amongst a younger group 
of men and women, in addition to a continuing trend of higher deaths due to cardiovascular 
disease, stroke, respiratory disease and cancer in middle-aged men and women.28 Indeed, 
premature male mortality increased from 1981 (and even more markedly from 1991) in 
some persistently deprived areas in Glasgow.11  
 
The cohorts included in this study were recruited in their middle age during the late 1960s 
and early 1970s. By 1981 (the first year in which we have been able to measure the ‘Scottish 
Effect’ using Carstairs deprivation index data), the surviving (and therefore healthier) 
participants in the Whitehall study were aged 52-78 years, in the Collaborative study were 
aged 53-75 years, and in the Renfrew & Paisley study were aged 50-73 years. Therefore, the 
Scottish cohorts are more likely to be representative of the populations affected by the 
earlier divergence in Scottish mortality (between 1950 and 1980) and of the continuing 
higher mortality amongst elderly men from cardiovascular disease, stroke and cancer than 
of the divergence in premature mortality occurring after 1980 which affected a younger age 
cohort. This therefore suggests that, not withstanding the difficulties in generalising from 
the occupational nature of two of the three cohorts, socio-economic circumstances may be 
the most important explanatory factor for the higher mortality during this earlier period of 
mortality divergence between 1950 and 1980, and amongst elderly men from the 1980s 
onwards.  
 
Implications of the study 
This study suggests that socio-economic status is the most important explanation for the 
higher mortality amongst Scottish middle aged men during the 1970s and amongst late 
middle aged and elderly men in the 1980s and 1990s. This means that the differences in 
observed male mortality are health inequalities as they arise from the social circumstances 
in which people live. This paper supports the large existing body of literature which suggests 
that a redistribution of income and power between socioeconomic groups and geographical 
areas is likely to be an effective means of reducing health inequalities.30 31 Comparisons of 
more recent and younger cohorts may be able to generate better insights into the more 
recent divergence in premature mortality between Scotland and England and in determining 
the causes of the ‘Scottish Effect’ which emerged from 1981 onwards.   
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Conclusions 
The higher all-cause male mortality in two Scottish cohorts compared to an English cohort 
all of which recruited participants in the late 1960s and early 1970s was accounted for 
mostly by differences in social class, and almost entirely by social class and cardiovascular 
risk factors, but not for some specific causes (stroke, alcohol-related causes, accidents and 
suicide). This provides further support for policy which redistributes income and power as a 
means to reducing health inequalities between social classes and geographical areas. The 
use of cohort studies which recruited younger groups from the 1980s onwards in Scotland 
and England may be able to shed further light on the causes of the divergent premature 
mortality trends during this later period.  
 
What this paper adds 
What is already known on the subject 
Mortality in Scotland has improved more slowly than England since the 1950s driven by 
cardiovascular disease, stroke and cancer. Since 1980, male premature mortality in Scotland 
has increased due to alcohol- and drug-related mortality, violence and suicide and has been 
increasingly inexplicable using area-based measures of socioeconomic deprivation.  
What this study adds 
Similar mortality differences are seen in cohort studies recruiting middle aged men in the 
1960s and 1970s, but these differences are largely explained by social class differences, and 
are almost completely explained by a combination of social class differences and 
cardiovascular risk factors.  
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Table 1 - Proportions and means+ for established risk factors by study 
 
 Whitehall 
  
(n = 13,884) 
Collaborative 
 
(n = 3,956) 
Renfrew & 
Paisley  
(n = 6,813) 
Age (years)  53.6 52.2 54.6 
Social class (%)    
   I, II 72.7 30.4 19.3 
   III NM 16.9 16.9 11.6 
   III M, IV, V 10.4 52.8 69.0 
    
Plasma cholesterol (mmol/l) 5.69 5.88 5.86 
Systolic blood pressure (mm Hg) 137.4 137.5 147.6 
Diastolic blood pressure (mm Hg) 85.0 84.9 85.8 
Body Mass Index (kg m-2) 25.6 25.2 25.9 
Height (cm) 172.9 171.9 169.7 
Smoking status (%):    
  Never 17.0 15.0 16.8 
  Ex 37.3 27.3 24.3 
  Current pipe or cigar smoker 3.5 2.5 1.9 
  Current cigarette smoker 42.2 55.2 57.0 
    
Cigarettes per day (smokers only) 16.1 18.8 20.5 
    
Forced Expiratory Volume in 1 second 
(FEV1) 
   
  Mean 3.07 2.81 2.56 
  Ratio to that predicted* 1.04 0.96 0.90 
Angina (%) 5.3 7.7 8.9 
Possible MI (%) 7.0 7.8 9.2 
ECG abnormalities (%) 7.2 7.3 9.8 
Respiratory symptoms (%)    
  No winter phlegm 76.4 69.8 63.5 
  Persistent phlegm 16.2 19.4 21.4 
  Infective phlegm 7.4 10.8 15.1 
    
Breathlessness (%) 6.1 7.2 12.9 
MRC Chronic bronchitis (%) 3.2 4.3 8.7 
 
+ Prevalences and means are adjusted for age (age is unadjusted). All measures show 
significant (p<0.001) heterogeneity between the studies 
* FEV ratio is the ratio of measured FEV divided by predicted FEV calculated from subjects’ 
age and height based on an equation derived in those men free of respiratory symptoms in 
the Renfrew & Paisley study. 
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Table 2 - Age adjusted mortality rates by study and time of follow-up 
 
                                                                                                     Follow-up period 
 0-9 years 10-19 years ≥20 years Total 
 Deaths Rate* (SE) Deaths Rate* (SE) Deaths Rate* (SE) Deaths Rate* (SE) 
 
All causes 
   Whitehall 1,557 12.1 (0.3) 2,793 28.0 (0.5) 7,336 84.4 (1.2) 11,686 35.8 (0.3) 
  Collaborative 527 16.1 (0.8) 897 36.0 (1.5) 1,818 84.4 (1.0) 3,242 38.7 (0.8) 
  Renfrew & Paisley 1,327 19.9 (0.6) 1,927 43.4 (1.6) 2,457 90.6 (1.1) 5,711 41.6 (0.6) 
 
CHD 
  Whitehall 665 5.2 (0.2) 969 9.6 (0.3) 1,785 20.2 (0.6) 3,419 10.6 (0.2) 
  Collaborative 235 7.0 (0.5) 346 13.4 (0.9) 464 21.0 (1.4) 1,045 12.4 (0.5) 
  Renfrew & Paisley 554 8.4 (0.4) 681 15.4 (0.6) 596 21.6 (1.0) 1,831 13.4 (0.3) 
 
Stroke 
  Whitehall 84 0.7 (0.1) 218 2.2 (0.2) 783 9.4 (0.4) 1,085 3.4 (0.1) 
  Collaborative 41 1.4 (0.3) 81 4.1 (0.6) 229 10.8 (1.0) 351 4.5 (0.3) 
  Renfrew & Paisley 94 1.4 (0.1) 192 4.4 (0.3) 334 13.1 (0.8) 620 4.5 (0.2) 
 
Respiratory diseases 
  Whitehall 100 0.8 (0.1) 284 3.0 (0.2) 1,171 15.0 (0.5) 1,555 4.9 (0.1) 
  Collaborative 23 0.8 (0.2) 74 3.2 (0.5) 238 13.4 (1.3) 335 4.3 (0.3) 
  Renfrew & Paisley 104 1.5 (0.2) 170 3.9 (0.3) 324 12.9 (0.9) 598 4.4 (0.2) 
 
Lung Cancer 
  Whitehall 180 1.4 (0.1) 264 2.7 (0.2) 344 3.7 (0.2) 788 2.5 (0.1) 
  Collaborative 69 2.1 (0.3) 90 3.6 (0.5) 148 5.3 (0.5) 307 3.5 (0.2) 
  Renfrew & Paisley 185 2.8 (0.2) 247 5.6 (0.4) 182 6.2 (0.5) 614 4.5 (0.2) 
 
Accidents and suicide 
  Whitehall 178 1.4 (0.1) 137 1.3 (0.1) 88 1.0 (0.1) 178 0.5 (0.1) 
  Collaborative 68 1.7 (0.2) 51 1.7 (0.3) 33 1.3 (0.3) 68 0.7 (0.1) 
  Renfrew & Paisley 117 1.8 (0.2) 81 1.8 (0.2) 49 1.9 (0.3) 117 0.9 (0.1) 
 
Alcohol-related   
  Whitehall 390 3.0 (0.2) 324 3.0 (0.2) 219 2.4 (0.2) 390 1.2 (0.1) 
  Collaborative 156 3.9 (0.3) 122 3.9 (0.4) 77 3.0 (0.5) 156 1.6 (0.2) 
  Renfrew & Paisley 298 4.8 (0.3) 215 4.8 (0.3) 127 4.3 (0.4) 298 2.2 (0.1) 
 
*Rates are given as the number of deaths per 1,000 person-years at risk 
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Table 3 - Hazard ratios for mortality in the Scottish cohorts compared to the Whitehall Study+ (reference) with successive adjustment for potential 
explanatory factors 
Adjusted for 
All-cause mortality CHD mortality Stroke mortality Respiratory mortality Lung cancer mortality Mortality due to accidents 
and suicide 
Alcohol-related mortality 
Collaborative Renfrew & 
Paisley 
Collaborative Renfrew &  
Paisley 
Collaborative Renfrew & 
Paisley 
Collaborative Renfrew & 
Paisley 
Collaborative Renfrew & 
Paisley 
Collaborative Renfrew & 
Paisley 
Collaborative Renfrew & 
Paisley 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
Age 1.25 
(1.21,1.30) 
1.41 
(1.36,1.45) 
1.32 
(1.23,1.41) 
1.41 
(1.33,1.50) 
1.55 
(1.37,1.75) 
1.73 
(1.57,1.92) 
1.05 
(0.93,1.18) 
1.17 
(1.07,1.29) 
1.65 
(1.45,1.89) 
1.98 
(1.78,2.21) 
1.77 
(1.33,2.36) 
2.00 
(1.56,2.55) 
1.73 
(1.44,2.09) 
2.28 
(1.95,2.67) 
Age, socio-
economic 
position 
1.08 
(1.04,1.13) 
1.17 
(1.12,1.21) 
1.17 
(1.09,1.26) 
1.22 
(1.14,1.31) 
1.45 
(1.27,1.66) 
1.60 
(1.42,1.80) 
0.78 
(0.69,0.88) 
0.82 
(0.73,0.92) 
1.16 
(1.01,1.35) 
1.30 
(1.14,1.47) 
1.56 
(1.14,2.13) 
1.70 
(1.27,2.27) 
1.47 
(1.20,1.81) 
1.85 
(1.53,2.24) 
Age, smoking 1.17 
(1.13,1.22) 
1.30 
(1.26,1.34) 
1.25 
(1.17,1.34) 
1.33 
(1.26,1.42) 
1.48 
(1.31,1.67) 
1.63 
(1.47,1.81) 
0.94 
(0.83,1.06) 
1.03 
(0.93,1.14) 
1.34 
(1.17,1.53) 
1.55 
(1.39,1.73) 
1.66 
(1.24,2.21) 
1.86 
(1.45,2.38) 
1.62 
(1.34,1.96) 
2.09 
(1.78,2.45) 
Age, FEV1 1.14 
(1.10,1.19) 
1.19 
(1.15,1.23) 
1.22 
(1.13,1.30) 
1.22 
(1.15,1.30) 
1.46 
(1.29,1.65) 
1.56 
(1.40,1.73) 
0.81 
(0.72,0.91) 
0.76 
(0.69,0.84) 
1.42 
(1.24,1.62) 
1.52 
(1.36,1.70) 
1.64 
(1.23,2.19) 
1.73 
(1.34,2.23) 
1.59 
(1.32,1.93) 
1.96 
(1.66,2.30) 
Age, cardio-
respiratory 
symptoms or 
history* 
1.22 
(1.18,1.27) 
1.31 
(1.27,1.35) 
1.29 
(1.20,1.38) 
1.30 
(1.23,1.38) 
1.54 
(1.36,1.74) 
1.67 
(1.50,1.85) 
0.98 
(0.87,1.11) 
0.99 
(0.90,1.10) 
1.57 
(1.37,1.79) 
1.79 
(1.60,1.99) 
1.72 
(1.29,2.29) 
1.85 
(1.45,2.37) 
1.70 
(1.40,2.05) 
2.13 
(1.82,2.49) 
Age, height 1.25 
(1.20,1.30) 
1.37 
(1.33,1.42) 
1.30 
(1.21,1.40) 
1.35 
(1.28,1.44) 
1.53 
(1.36,1.73) 
1.67 
(1.51,1.86) 
1.03 
(0.92,1.16) 
1.12 
(1.01,1.23) 
1.65 
(1.44,1.88) 
1.95 
(1.75,2.18) 
1.74 
(1.31,2.32) 
1.90 
(1.48,2.43) 
1.70 
(1.41,2.06) 
2.16 
(1.84,2.53) 
Age, body 
mass index 
 
1.25 
(1.20,1.30) 
1.39 
(1.35,1.44) 
1.33 
(1.24,1.43) 
1.38 
(1.30,1.46) 
1.55 
(1.37,1.75) 
1.71 
(1.54,1.89) 
1.01 
(0.90,1.14) 
1.19 
(1.08,1.31) 
1.60 
(1.40,1.83) 
2.02 
(1.81,2.25) 
1.73 
(1.30,2.30) 
2.02 
(1.58,2.58) 
1.72 
(1.42,2.07) 
2.26 
(1.93,2.64) 
Age, systolic 
and diastolic 
blood pressure 
1.26 
(1.21,1.31) 
1.33 
(1.29,1.38) 
1.34 
(1.25,1.43) 
1.28 
(1.20,1.36) 
1.58 
(1.40,1.79) 
1.56 
(1.41,1.73) 
1.05 
(0.93,1.18) 
1.15 
(1.04,1.27) 
1.66 
(1.45,1.89) 
1.98 
(1.77,2.21) 
1.77 
(1.33,2.35) 
2.15 
(1.67,2.77) 
1.73 
(1.44,2.09) 
2.30 
(1.95,2.70) 
Age, 
cholesterol  
1.24 
(1.20,1.29) 
1.40 
(1.35,1.44) 
1.28 
(1.19,1.37) 
1.38 
(1.30,1.46) 
1.55 
(1.37,1.76) 
1.74 
(1.57,1.93) 
1.07 
(0.95,1.21) 
1.20 
(1.09,1.32) 
1.70 
(1.49,1.94) 
2.04 
(1.83,2.27) 
1.79 
(1.34,2.38) 
2.02 
(1.58,2.58) 
1.77 
(1.47,2.14) 
2.33 
(1.99,2.73) 
Multiply± 
adjusted 
without socio-
economic 
position  
1.09 
(1.05,1.14) 
1.07 
(1.03,1.10) 
1.16 
(1.08,1.25) 
1.01 
(0.95,1.08) 
1.44 
(1.28,1.64) 
1.36 
(1.21,1.52) 
0.75 
(0.67,0.85) 
0.70 
(0.63,0.78) 
1.24 
(1.08,1.42) 
1.38 
(1.22,1.55) 
1.57 
(1.18,2.11) 
1.78 
(1.36,2.33) 
1.56 
(1.29,1.89) 
1.88 
(1.58,2.23) 
Multiply± 
adjusted 
including 
socio-
economic 
position  
1.03 
(0.98,1.07) 
0.99 
(0.95,1.03) 
1.11 
(1.03,1.20) 
0.96 
(0.89,1.03) 
1.45 
(1.27,1.66) 
1.37 
(1.21,1.55) 
0.70 
(0.61,0.79) 
0.65 
(0.58,0.73) 
1.06 
(0.92,1.23) 
1.16 
(1.01,1.33) 
1.51 
(1.11,2.07) 
1.70 
(1.25,2.30) 
1.46 
(1.19,1.80) 
1.73 
(1.42,2.11) 
+ Analyses for all-cause mortality are based on 13,884, 3,956 and 6,813 men in the Whitehall, Collaborative and Renfrew & Paisley studies respectively. For cause-specific mortality the number of men in the analyses are 
13,850, 3,948 and 6,792 respectively. The number of deaths is given in Table 2.  
* Angina, ECG abnormality, respiratory symptoms or breathlessness.  
± Multiply adjusted for :- age, smoking, FEV1, cardio-respiratory symptoms or history, height, systolic blood pressure, cholesterol, body mass index.  
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Table 4 - Proportions and means+ for established risk factors in the Whitehall, Collaborative and Renfrew & Paisley studies by social class 
 
 Social classes I & II Social class III NM Social classes IIIM, IV, V 
 Whitehall 
 
(N=10114) 
Collaborative 
 
(N=1220) 
Renfrew & 
Paisley 
(N=1297) 
Whitehall 
 
(N=2333) 
Collaborative 
 
(N=664) 
Renfrew & Paisley 
(N=804) 
Whitehall 
 
(N=1437) 
Collaborative 
 
(N=2072) 
Renfrew & 
Paisley 
(N=4712) 
Age (years)  52.6 51.8 54.0 55.4 52.5 55.3 57.1 52.3 54.7 
Plasma cholesterol 
(mmol/l) 
5.71 6.24 6.01 5.69 6.02 5.94 5.54 5.64 5.80 
Systolic blood pressure 
(mm Hg) 
137.2 134.2 146.9 137.7 136.2 148.0 138.9 139.6 147.8 
Diastolic blood pressure 
(mm Hg) 
84.9 83.9 85.8 84.9 84.2 85.9 85.7 85.6 85.9 
Body Mass Index (kg m-2) 25.6 25.2 26.0 25.4 25.2 25.7 25.6 25.3 25.8 
Height (cm) 173.6 174.8 171.8 171.4 172.7 171.3 170.7 170.0 168.8 
Smoking status (%):          
  Never 18.4 18.2 22.7 13.8 16.8 18.5 11.0 12.5 14.9 
  Ex 40.9 33.5 30.4 30.3 26.8 26.8 24.1 23.9 22.2 
  Current pipe or cigar 4.0 3.7 2.6 1.8 2.1 1.6 2.5 1.9 1.7 
  Current cigarettes 36.8 44.6 44.2 54.1 54.3 53.1 62.3 61.7 61.2 
Cigarettes per day 
(smokers only) 
16.0 20.0 21.2 16.3 18.0 20.0 16.3 18.5 20.4 
          
Forced Expiratory Volume 
in 1 second (FEV1) 
         
  Mean 3.18 3.10 2.80 2.85 2.89 2.65 2.74 2.63 2.47 
  Ratio to that predicted* 1.06 1.02 0.96 0.98 0.98 0.91 0.95 0.92 0.88 
Angina (%) 5.1 6.0 6.9 5.6 8.2 10.0 5.4 8.6 9.3 
Possible MI (%) 6.7 5.6 8.0 6.7 8.9 9.7 9.2 8.6 9.5 
ECG abnormalities (%) 6.8 6.1 9.7 7.9 8.9 10.6 9.1 7.4 9.6 
Respiratory symptoms (%)          
  No winter phlegm 79.4 77.3 72.3 70.4 69.5 70.0 66.2 65.7 60.4 
  Persistent phlegm 14.6 15.3 19.4 19.5 21.5 19.6 20.8 21.0 22.3 
  Infective phlegm 6.0 7.4 8.3 10.1 8.7 10.4 13.0 13.3 17.3 
          
Breathlessness (%) 4.8 3.4 7.1 8.4 9.1 11.7 11.6 8.7 14.6 
MRC Chronic bronchitis 
(%) 
2.1 1.5 4.3 5.2 5.0 6.2 6.7 5.6 10.3 
+ Prevalences and means are adjusted for age (age is unadjusted) 
* FEV ratio is the ratio of measured FEV divided by predicted FEV calculated from subjects’ age and height based on an equation derived in those men free of respiratory 
symptoms in the Renfrew & Paisley study.  
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Table 5 - Hazard ratios for all-cause mortality in the Scottish cohorts compared to the Whitehall Study+ (reference) separately by social class with 
successive adjustment for potential explanatory factors  
 
 
Social classes I & II Social class III NM Social classes IIIM, IV, V 
Whitehall  Collaborative Renfrew & 
Paisley 
Whitehall  Collaborative Renfrew 
& Paisley 
Whitehall  Collaborative Renfrew 
& Paisley 
Number of subjects 10114 1220 1297 2333 664 804 1437 2072 4712 
Number of deaths 8251 923 1004 2097 560 681 1338 1759 4026 
H
az
ar
d 
ra
ti
o 
(9
5%
 C
I)
 fo
r 
al
l –
ca
us
e 
m
or
ta
lit
y 
ad
ju
st
ed
 fo
r 
: Age 1.0 1.09 
(1.02,1.17) 
1.22 
(1.14,1.30) 
 
1.0 
1.03  
(0.93,1.13) 
1.11  
(1.01,1.21) 
1.0 1.06 
(0.98,1.14) 
1.13  
(1.06,1.21) 
Age, smoking 1.0 1.03 
(0.96,1.10) 
1.16 
(1.08,1.24) 
 
1.0 
1.00  
(0.91,1.10) 
1.09  
(1.00,1.20) 
1.0 1.07 
(1.00,1.16) 
1.14  
(1.07,1.22) 
Age, FEV1 1.0 1.05 
(0.98,1.12) 
1.10 
(1.02,1.17) 
 
1.0 
1.03  
(0.94,1.14) 
1.05  
(0.96,1.14) 
1.0 1.01 
(0.94,1.09) 
1.04  
(0.97,1.11) 
Age, cardio-respiratory 
symptoms or history* 
1.0 1.09 
(1.02,1.17) 
1.18 
(1.10,1.26) 
 
1.0 
1.02  
(0.92,1.12) 
1.07  
(0.98,1.17) 
1.0 1.04 
(0.96,1.12) 
1.07  
(1.01,1.15) 
Age, height 1.0 1.09 
(1.02,1.17) 
1.21 
(1.13,1.29) 
 
1.0 
1.03  
(0.94,1.13) 
1.11  
(1.01,1.21) 
1.0 1.05 
(0.97,1.13) 
1.11  
(1.04,1.18) 
Age, body mass index 1.0 1.10 
(1.03,1.18) 
1.21 
(1.13,1.29) 
 
1.0 
1.02  
(0.93,1.13) 
1.10  
(1.01,1.21) 
1.0 1.06 
(0.98,1.14) 
1.14  
(1.07,1.21) 
Age, systolic and 
diastolic blood pressure 
1.0 1.11 
(1.04,1.19) 
1.14 
(1.07,1.22) 
 
1.0 
1.03  
(0.94,1.14) 
1.04  
(0.96,1.14) 
1.0 1.06 
(0.99,1.14) 
1.10  
(1.03,1.17) 
Age, cholesterol  1.0 1.06 
(0.99,1.13) 
1.20 
(1.12,1.28) 
 
1.0 
1.01  
(0.91,1.11) 
1.09  
(1.00,1.19) 
1.0 1.05 
(0.98,1.14) 
1.12  
(1.05,1.20) 
          
Multiply± adjusted   1.0 1.00 
(0.94,1.08) 
0.99 
(0.93,1.06) 
 
1.0 
0.96  
(0.87,1.06) 
 
 
0.95  
(0.86,1.04) 
1.0 1.04 
(0.97,1.13) 
1.02  
(0.95,1.09) 
 
* Angina, ECG abnormality, respiratory symptoms or breathlessness.  
± Multiply adjusted for :- age, smoking, FEV1, cardio-respiratory symptoms or history, height, systolic blood pressure, cholesterol, body mass index 
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Table 6 - Hazard ratios for all-cause mortality in the Scottish cohorts compared to the Whitehall Study+ (reference) by time of follow-up  
 
 
Follow-up period 0-9 years Follow-up period 10-19 years Follow-up period 20+ years 
Whitehall  Collaborative Renfrew & 
Paisley 
Whitehall  Collaborative Renfrew 
& Paisley 
Whitehall  Collaborative Renfrew 
& Paisley 
Number of subjects 13884 3956 6813 12239 3417 5452 9375 2508 3515 
Number of deaths 1557 527 1327 2793 897 1927 7336 1818 2457 
H
az
ar
d 
ra
ti
o 
(9
5%
 C
I)
 fo
r 
al
l  
–c
au
se
 m
or
ta
lit
y 
ad
ju
st
ed
 fo
r:
 Age 1.0 1.45 
(1.31,1.60) 
1.64 
(1.53,1.77) 
1.0 1.40  
(1.30,1.51) 
1.56  
(1.47,1.65) 
1.0 1.15 
(1.09,1.21) 
1.25  
(1.19,1.21) 
          
Multiply± 
adjusted without 
socio-economic 
position  
1.0 1.20 
(1.09,1.33) 
1.10 
(1.01,1.19) 
1.0 1.21 
(1.12,1.30) 
1.13 
(1.07,1.22) 
1.0 1.02 
(0.97,1.08) 
1.01  
(0.96,1.07) 
Multiply± 
adjusted 
including socio-
economic 
position  
1.0 1.10 
(0.99,1.23) 
1.01 
(0.92,1.11) 
1.0 1.13  
(1.05,1.23) 
1.07  
(0.99,1.15) 
1.0 0.96 
(0.91,1.02) 
0.95  
(0.89,1.00) 
 
± Multiply adjusted for :- age, smoking, FEV1, cardio-respiratory symptoms or history, height, systolic blood pressure, cholesterol, body mass index 
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Web-table 7 - Sensitivity analyses showing hazard ratios for mortality in the Scottish cohorts compared to the Whitehall Study+ (reference) when 
Whitehall heights are reduced by half an inch (rather than one inch) 
 
Adjusted for 
All-cause mortality CHD mortality Stroke mortality Respiratory mortality 
 
Lung cancer 
mortality 
Mortality due to 
accidents and suicide 
Alcohol-
related 
mortality 
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HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
Age 1.25 
(1.21,1.30) 
1.41 
(1.36,1.45) 
1.32 
(1.23,1.41) 
1.41 
(1.33,1.50) 
1.55 
(1.37,1.75) 
1.73 
(1.57,1.92) 
1.05 
(0.93,1.18) 
1.17 
(1.07,1.29) 
1.65 
(1.45,1.89) 
1.98 
(1.78,2.21) 
1.77 
(1.33,2.36) 
2.00 
(1.56,2.55) 
1.73 
(1.44,2.09) 
2.28 
(1.95,2.67) 
Age, height 1.23 
(1.18,1.28) 
1.36 
(1.31,1.40) 
1.28 
(1.19,1.37) 
1.33 
(1.25,1.41) 
1.51 
(1.34,1.71) 
1.65 
(1.48,1.83) 
1.01 
(0.90,1.14) 
1.09 
(0.99,1.21) 
1.63 
(1.43,1.87) 
1.94 
(1.73,2.17) 
1.71 
(1.28,2.28) 
1.86 
(1.44,2.39) 
1.67 
(1.38,2.01) 
2.11 
(1.79,2.48) 
Age, body mass 
index 
 
1.25 
(1.20,1.30) 
1.39 
(1.35,1.44) 
1.31 
(1.22,1.41) 
1.36 
(1.28,1.44) 
1.54 
(1.36,1.74) 
1.69 
(1.53,1.87) 
1.04 
(0.93,1.18) 
1.22 
(1.11,1.34) 
1.65 
(1.45,1.89) 
2.08 
(1.87,2.32) 
1.77 
(1.33,2.35) 
2.06 
(1.61,2.63) 
1.73 
(1.43,2.09) 
2.27 
(1.94,2.65) 
               
Multiply± adjusted 
without socio-
economic position  
1.10 
(1.05,1.14) 
1.07 
(1.03,1.11) 
1.15 
(1.07,1.23) 
1.00 
(0.94,1.07) 
1.44 
(1.27,1.63) 
1.35 
(1.21,1.51) 
0.78 
(0.69,0.88) 
0.73 
(0.65,0.81) 
1.27 
(1.11,1.46) 
1.42 
(1.26,1.60) 
1.58 
(1.18,2.11) 
1.79 
(1.36,2.34) 
1.55 
(1.27,1.87) 
1.86 
(1.56,2.21) 
Multiply± adjusted 
including socio-
economic position  
1.03 
(0.99,1.08) 
1.00 
(0.96,1.04) 
1.10 
(1.02,1.18) 
0.95 
(0.88,1.02) 
1.45 
(1.27,1.65) 
1.36 
(1.20,1.54) 
0.72 
(0.63,0.82) 
0.67 
(0.60,0.76) 
1.09 
(0.95,1.27) 
1.20 
(1.05,1.37) 
1.52 
(1.11,2.08) 
1.70 
(1.25,2.31) 
1.45 
(1.18,1.78) 
1.72 
(1.41,2.10) 
 
+ Analyses for all-cause mortality are based on 13,884,3956 and 6813  men in the Whitehall, Collaborative and Renfrew & Paisley  studies respectively.  For cause specific 
mortality the number of men in the analyses are 13850, 3948 and 6792 respectively. The number of deaths is given in Table 2.  
* Angina, ECG abnormality, respiratory symptoms or breathlessness.  
± Multiply adjusted for :- age, smoking, FEV1, cardio-respiratory symptoms or history, height, systolic blood pressure, cholesterol, body mass index 
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Web-table 8 - Sensitivity analyses showing hazard ratios for all-cause mortality in the Scottish cohorts compared to the Whitehall Study+ (reference) 
when Whitehall heights are reduced by half an inch (rather than one inch)  
 
 
Social classes I & II Social class III NM Social classes IIIM, IV, V 
Whitehall I Collaborative Renfrew & Paisley Whitehall I Collaborative Renfrew 
 & Paisley 
Whitehall I Collaborative Renfrew 
& Paisley 
Number of subjects 10114 1220 1297 2333 664 804 1437 2072 4712 
Number of deaths 8251 923 1004 2097 560 681 1338 1759 4026 
          
Age, height 1.0 1.09 
(1.02,1.17) 
1.21 
(1.13,1.29) 
1.0 1.03  
(0.93,1.13) 
1.11  
(1.01,1.21) 
1.0 1.03 
(0.96,1.11) 
1.10  
(1.03,1.17) 
Age, body mass index 1.0 1.09 
(1.02,1.17) 
1.19 
(1.12,1.28) 
1.0 1.02  
(0.93,1.12) 
1.10  
(1.01,1.20) 
1.0 1.07 
(0.99,1.15) 
1.14  
(1.07,1.22) 
          
Multiply± adjusted   1.0 1.01 
(0.94,1.08) 
1.00 
(0.93,1.07) 
1.0 0.97  
(0.88,1.07) 
0.95  
(0.87,1.05) 
1.0 1.05 
(0.97,1.13) 
1.02  
(0.95,1.09) 
 
* Angina, ECG abnormality, respiratory symptoms or breathlessness.  
± Multiply adjusted for :- age, smoking, FEV1, cardio-respiratory symptoms or history, height, systolic blood pressure, cholesterol, body mass index 
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